Effectiveness of hepatitis A vaccination as post-exposure prophylaxis

References

• Ciocca M. Clinical course and consequences of hepatitis A infection. Vaccine 2000; 18:S71-S74; PMID:10683554; http://dx.doi.org/10.1016/S0264-410X(99)00470-3
   PubMed Web of Science ®Google Scholar
• Murphy TV, Feinstone SM, Bell BP. Hepatitis A vaccines. In: Plotkin SA, Orenstein WA, Offit PA, eds. Vaccines. 6th ed. Philadelphia: Elsevier, 2013: 183-204.
   Google Scholar
• Averhoff F, Khudyakov Y, Bell BP. Hepatitis A virus. In: Bennet JE, Dolin R, Blaser MJ, eds. Principles and Practice of Infectious Diseases. 8th ed. Philadelphia: Elsevier, 2015: 2095-112.
   Google Scholar
• Lednar WM, Lemon SM, Kirkpatrik JW, Redfield RR, Fields ML, Kelley PW. Frequency of illness associated with epidemic hepatitis in adults. Am J Epidemiol 1985; 122:226-33; PMID:3860002.
   PubMed Web of Science ®Google Scholar
• Blechová Z, Trojánek M, Kynčl J, Cástková J, John J, Malý M, Herrmannová K, Marešová V. Clinical and laboratory features of viral hepatitis A in children. Wien Klin Wochenschr 2013; 125:83-90; http://dx.doi.org/10.1007/s00508-012-0316-9
   PubMed Web of Science ®Google Scholar
• Bura M, Michalak M, Chojnicki MK, Kowala-Piaskowska A, Mozer-Lisewska I. Viral hepatitis A in 108 adult patients during an eight-year observation at a single center in Poland. Adv Clin Exp Med 2015; 24:829-36; PMID:26768634; http://dx.doi.org/10.17219/acem/27566
   PubMed Web of Science ®Google Scholar
• Heyman DL, editor. Control of communicable diseases manual. 20th ed. Washington: American Public Health Association, 2015.
   Google Scholar
• FitzSimons D, Hendrickx G, Vorsters A, Van Damme P. Hepatitis A and E: update on prevention and epidemiology. Vaccine 2010; 28:583-8; PMID:19925903; http://dx.doi.org/10.1016/j.vaccine.2009.10.136
   PubMed Web of Science ®Google Scholar
• Donnan EJ, Fielding JE, Gregory JE, Lalor K, Rowe S, Goldsmith P, Antoniou M, Fullerton KE, Knope K, Copland JG, et al. A multistate outbreak of hepatitis A associated with semidried tomatoes in Australia, 2009. Clin Infect Dis 2012; 54:775-81.
   PubMed Web of Science ®Google Scholar
• Robesyn E, De Schrijver K, Wollants E, Top G, Verbeeck J, Van Ranst M. An outbreak of hepatitis A associated with the consumption of raw beef. J Clin Virol 2009; 44:207-10; PMID:19179106; http://dx.doi.org/10.1016/j.jcv.2008.12.012
   PubMed Web of Science ®Google Scholar
• Guillois-Bécel Y, Couturier E, Le Saux JC, Roque-Afonso AM, Le Guyader FS, Le Goas A, Pernès J, Le Bechec S, Briand A, Robert C, et al. An oyster-associated hepatitis A outbreak in France in 2007. Euro Surveill 2009; 14. pii: 19144.
   PubMedGoogle Scholar
• Collier MG, Khudyakov YE, Selvage D, Adams-Cameron M, Epson E, Cronquist A, Jervis RH, Lamba K, Kimura AC, Sowadsky R. Outbreak of hepatitis A in the USA associated with frozen pomegranate arils imported from Turkey: an epidemiological case study. Lancet Infect Dis 2014; 14:976-81; PMID:25195178; http://dx.doi.org/10.1016/S1473-3099(14)70883-7
   PubMed Web of Science ®Google Scholar
• Frank C, Walter J, Muehlen M, Jansen A, van Treeck U, Hauri AM, Zoellner I, Rakha M, Hoehne M, Hamouda O, et al. Major outbreak of hepatitis A associated with orange juice among tourists, Egypt, 2004. Emerg Infect Dis 2007; 13:156-8; PMID:17370535; http://dx.doi.org/10.3201/eid1301.060487
   PubMed Web of Science ®Google Scholar
• Severi E, Verhoef L, Thorton L, Guzman-Herrador BR, Faber M, Sundqvist L, Rimhanen-Finne R, Rique Afonso AM, Ngui SL, Allergerger F, et al. Large and prolonged food-borne multistate hepatitis A outbreak in Europe associated with consumption of frozen berries, 2013 to 2014. Euro Surveill 2015; 23(20):21192; http://dx.doi.org/10.2807/1560-7917.ES2015.20.29.21192
   Google Scholar
• Gervelmeyer A, Nielsen MS, Frey LC, Sckerl H, Damberg E, Mølbak K. An outbreak of hepatitis A among children and adults in Denmark, August 2002 to February 2003. Epidemiol Infect 2006; 134:485-91; PMID:16194292; http://dx.doi.org/10.1017/S0950268805005200
   PubMed Web of Science ®Google Scholar
• Lima LR, De Almeida AJ, Tourinho Rdos S, Hasselmann B, Ximenez LL, De Paula VS. Evidence of hepatitis A virus person-to-person transmission in household outbreaks. PLoS One 2014; 9:e102925; PMID:25050760; http://dx.doi.org/10.1371/journal.pone.0102925
   PubMedGoogle Scholar
• Domínguez A, Salleras L, Carmona G, Batalla J. Effectiveness of a mass hepatitis A vaccination program in preadolescents. Vaccine 2003; 21:698-701; http://dx.doi.org/10.1016/S0264-410X(02)00583-2
   PubMed Web of Science ®Google Scholar
• Stokes J, Neefe JR. The prevention and attenuation of infectious hepatitis by gamma globulin. JAMA 1945; 127:144-5; http://dx.doi.org/10.1001/jama.1945.02860030016004
   Web of Science ®Google Scholar
• Stapleton JT. Passive immunization against hepatitis A. Vaccine 1992; 10 (suppl 1):S45-S47; PMID:1335658; http://dx.doi.org/10.1016/0264-410X(92)90541-Q
   PubMedGoogle Scholar
• Hsu JL, Safdar N. Polyclonal immunoglobulins and hyperimmune globulins in prevention and management of infectious diseases. Infect Dis Clin North Am 2011; 25:773-88; PMID:22054755; http://dx.doi.org/10.1016/j.idc.2011.07.005
   PubMed Web of Science ®Google Scholar
• Taliani G, Gaeta GB. Hepatitis A: post-exposure prophylaxis. Vaccine 2003; 21:2234-7; PMID:12744848; http://dx.doi.org/10.1016/S0264-410X(03)00138-5
   PubMed Web of Science ®Google Scholar
• Mosley JW, Reisler DM, Brachott D, Roth D, Weiser J. Comparison of two lots of immune serum globulin for prophylaxis of infectious hepatitis. Am J Epidemiol 1968; 87:539-50; PMID:4297614.
   PubMed Web of Science ®Google Scholar
• Lemon SM. Type A viral hepatitis: new development in an old disease. N Engl J Med 1985; 313:1059-67; PMID:2413356; http://dx.doi.org/10.1056/NEJM198510243131706
   PubMed Web of Science ®Google Scholar
• American Academy of Pediatrics. In: Kimberlin DW, Brady MT, Jackson MA, Long SS, eds. Red Book: 2015 Report of the committee on infectious diseases. 30th ed. Elk Grove Village, IL: American Academy of Pediatrics, 2015:391-9.
   Google Scholar
• Vizzotti C, González J, Gentile A, Rearte A, Ramonet M, Cañero-Velasco MC, Pérez-Carrega ME, Urueña A, Diosque M. Impact of the single-dose immunization strategy against hepatitis A in Argentina. Pediatr Infect Dis J 2014; 33:84-8; PMID:24352191; http://dx.doi.org/10.1097/INF.0000000000000042
   PubMed Web of Science ®Google Scholar
• Reuman PD, Kubilis P, Hurni W, Brown L, Nalin D. The effect of age and weight on the response to formalin inactivated, alum-adjuvanted hepatitis A vaccine in healthy adults. Vaccine 1997; 15:1157-61; PMID:9269062; http://dx.doi.org/10.1016/S0264-410X(96)00310-6
   PubMed Web of Science ®Google Scholar
• Bonanni P, Franzin A, Staderini C, Pitta M, Garofalo G, Cecconi R, Santini MG, Lai P, Innocenti B. Vaccination against hepatitis A during outbreaks starting in schools: what can we learn from experiences in central Italy? Vaccine 2005; 23:2176-80; PMID:15755590; http://dx.doi.org/10.1016/j.vaccine.2005.01.044
   PubMed Web of Science ®Google Scholar
• Arce Arnáez A, Cabello Ballesteros L, Iñigo Martínez J. Community outbreak of hepatitis A in a marginal population. Vaccination for its control and acceptance of the measure. Aten Primaria 2007; 39:139-43.
   PubMed Web of Science ®Google Scholar
• Hall V, Abrahams A, Turbitt D, Cathcart S, Maguire H, Balasegaram S. No evidence of transmission from an acute case of hepatitis A in a foodhandler: follow-up of almost 1,000 potentially exposed individuals, London, United Kingdom, April 2012. Euro Surveill 2014; 19. pii:20865.
   Google Scholar
• Zamir C, Risphon S, Zamir D, Leventhal A, Rimon N, Ben-Porath E. Control of a community-wide with inactivated hepatitis A vaccine. Eur J Clin Microbiol Infect Dis 2001; 20:185-7; PMID:11347668.
   PubMed Web of Science ®Google Scholar
• Shen YG, Gu XJ, Zhou JH. Protective effect of inactivated hepatitis A vaccine against the outbreak of hepatitis A in an open rural community. World J Gastroenterol 2008; 14:2771-5; PMID:18461664; http://dx.doi.org/10.3748/wjg.14.2771
   PubMed Web of Science ®Google Scholar
• Díaz Villaescusa MJ, Almar Marqués E, Gómez Martínez A, Mateos Ramos A, Segura Cebollada P, de la Cruz de Julián I, Navarro Honrubia C, Ramírez Córcoles C. [Study of a population outbreak of hepatitis A. Effectiveness of vaccination as a control measure] [Article in Spanish]. Gac Sanit 2010; 24:329-33; http://dx.doi.org/10.1016/j.gaceta.2010.02.010
   PubMed Web of Science ®Google Scholar
• Victor JC, Monto AS, Surdina TY, Suleimenova SZ, Vaughan G, Nainan OV, Favorov MO, Margolis HS, and Bell BP. Hepatitis A vaccine versus immune globulin for postexposure prophylaxis. N Engl J Med 2007; 357:1685-94; PMID:17947390; http://dx.doi.org/10.1056/NEJMoa070546
   PubMed Web of Science ®Google Scholar
• Sagliocca L, Amoroso P, Stroffolini T, Adamo B, Tosti ME, Lettieri G, Esposito C, Buonocore S, Pierri P, Mele A. Efficacy of hepatitis A vaccine in prevention of secondary hepatitis A infection: a randomised trial. Lancet 1999; 353:1136-9; PMID:10209977; http://dx.doi.org/10.1016/S0140-6736(98)08139-2
   PubMed Web of Science ®Google Scholar
• Novak R, Williams I, Bell B. Update: Prevention of hepatitis A after exposure to hepatitis A virus and in international travelers. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2007; 56:1080-4; PMID:17947967.
   PubMedGoogle Scholar
• Nelson NP, Murphy TV, McMahon BJ. Hepatitis A vaccination for post-exposure prophylaxis in persons aged 40 years and older. Vaccine 2014; 32:2939; PMID:24530928; http://dx.doi.org/10.1016/j.vaccine.2014.01.086
   PubMed Web of Science ®Google Scholar
• Freeman E, Lawrence G, McAnulty J, Tobin S, MacIntyre CR, Torvaldsen S. Field effectiveness of hepatitis A vaccine and uptake of post exposure prophylaxis following a change to the Australian guidelines. Vaccine 2014; 32:5509-13; PMID:25111168; http://dx.doi.org/10.1016/j.vaccine.2014.07.048
   PubMed Web of Science ®Google Scholar
• Van Deer Meren O, Crasta P, de Ridder M. A retrospective pooled analysis assessing the effect of age on immunogenicity of Havrix™ in healthy adults. Hum Vacc Immunother 2015; 11:1729-33; http://dx.doi.org/10.1080/21645515.2015.1045167
   PubMed Web of Science ®Google Scholar
• Farcet MR, Planitzer CB, Stein O, Modrof J, Kreil TR. Hepatitis A virus antibodies in immunoglobulin preparations. J Allergy Clin Immunol 2010; 125:198-202; PMID:19962745; http://dx.doi.org/10.1016/j.jaci.2009.09.008
   PubMed Web of Science ®Google Scholar
• Van Damme P, Mathei C, Thoelen S, Meheus A, Safary A, Andre FE. Single dose inactivated hepatitis A vaccine: rationale and clinical assessment of the safety and immunogenicity. J Med Virol 1994; 44:435-441; PMID:7897376; http://dx.doi.org/10.1002/jmv.1890440422
   PubMed Web of Science ®Google Scholar
• Shouval D, Ashur Y, Adler R, Lewis JA, Miller W, Kuter B, Brown L, Nalin DR. Safety, tolerability, and immunogenicity of an inactivated hepatitis A vaccine: effects of single and booster injections, and comparison to administration of immune globulin. J Hepatol 1993; 18 (Suppl 2):S32-37; PMID:8182270; http://dx.doi.org/10.1016/S0168-8278(05)80375-7
   PubMedGoogle Scholar
• Demicheli V, Tiberti D. The effectiveness and safety of hepatitis A vaccine: a systematic review. Vaccine 2003; 21:2242-45; PMID:12744850; http://dx.doi.org/10.1016/S0264-410X(03)00135-X
   PubMed Web of Science ®Google Scholar
• Kohl I, Nemecek V, Summerová M, Chlíbek R, Nad'ová K, Mináriková O. Long-term protective effect of post-exposure Havrix™ administration during viral hepatitis type A outbreaks. Eur J Epidemiol 2006; 21:893-9; PMID:17160428; http://dx.doi.org/10.1007/s10654-006-9081-2
   PubMed Web of Science ®Google Scholar
• Hens N, Ghebretinsae AH, Hardt K, Van Damme P, Van Herck K. Model based estimates of long-term persistence of inactivated hepatitis A vaccine-induced antibodies in adults. Vaccine 2014; 32:1507-13; PMID:24508042; http://dx.doi.org/10.1016/j.vaccine.2013.10.088
   PubMed Web of Science ®Google Scholar
• Weinberg A, Gona P, Nachman SA, Defechereux P, Yogev R, Hughes W, Wara D, Spector SA, Read J, Elgie C. Antibody responses to hepatitis A virus vaccine in HIV-infected children with evidence of immunologic reconstitution while receiving highly active antiretroviral therapy. J Infect Dis 2006; 193:302-11; PMID:16362896; http://dx.doi.org/10.1086/498979
   PubMed Web of Science ®Google Scholar
• World Health Organization. The immunological basis for immunization series. Module 18: hepatitis A. Geneva: World Health Organization, 2011.
   Google Scholar
• Department of Health. [Case definition for compulsory reportable diseases] [In Catalan]. Barcelona: Generalitat of Catalonia, 2011.
   Google Scholar
• Martin D, Austin H. Exact estimates for a rate ratio. Epidemiology 1996; 7:29-33; PMID:8664397; http://dx.doi.org/10.1097/00001648-199601000-00006
   PubMed Web of Science ®Google Scholar